Drug Type Small molecule drug |
Synonyms AVA ADR 001, AVA ADR-001, AVA-ADR 001 + [3] |
Target |
Action inhibitors |
Mechanism ADAR1p150 inhibitors(ADAR1p150 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | India | 22 Mar 2024 | |
| Melanoma | Preclinical | United States | 06 Nov 2022 |





